Gritstone Oncology Inc at Barclays Global Healthcare Conference Transcript
Thank you, everyone. My name is Gena Wang. I'm mid cap biotech analyst at the Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team and the corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our first speaker today, Andrew Allen, Chief Executive Officer from Gritstone. Andrew, I'll hand over to you.
Thank you, Gena. Good morning, everybody. This is Andrew Allen, the -- one of the co-founders, President and CEO of Gritstone Oncology. And my presentation, I will move through swiftly this morning so that we have time for some Q&A.
If you would turn to Slide 3 of the presentation -- Slide 2, obviously, making some points regarding forward-looking statements. On Slide 3, you can see an overview of the company. We are a neoantigen-based
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |